Ultrinia Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Ultrinia General Information
Description
Developer of biomimetic biomaterials intended to offer improved specificity of drug carriers and contrast agents. The company develops unique scaffolds, filling the gap between two-dimensional (2D) and three-dimensional (3D) options, enabling medical researchers to enhance drug delivery precision and advance regenerative medicine research, ultimately leading to better outcomes for patients.
Contact Information
Website
www.ultrinia.comCorporate Office
- Tallinn
- Estonia
Corporate Office
- Tallinn
- Estonia
Ultrinia Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Accelerator/Incubator | Completed | Generating Revenue | ||||
1. Seed Round | 03-Sep-2014 | Completed | Generating Revenue |
Ultrinia Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Prototron | Accelerator/Incubator | Minority | ||
Tehnopol Startup Incubator | Accelerator/Incubator | Minority |
Ultrinia FAQs
-
Where is Ultrinia headquartered?
Ultrinia is headquartered in Tallinn, Estonia.
-
What industry is Ultrinia in?
Ultrinia’s primary industry is Drug Delivery.
-
Is Ultrinia a private or public company?
Ultrinia is a Private company.
-
What is Ultrinia’s current revenue?
The current revenue for Ultrinia is
. -
How much funding has Ultrinia raised over time?
Ultrinia has raised $66.4K.
-
Who are Ultrinia’s investors?
Prototron and Tehnopol Startup Incubator have invested in Ultrinia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »